725 - the TCS/TCI-free Rate Remains High and Stable While on Lebrikizumab for Treatment of Moderate-to-severe Atopic Dermatitis over 1 Year
BRITISH JOURNAL OF DERMATOLOGY（2024）
关键词
moderate-to-severe,interleukin-13,topical corticosteroids,topical calcineurin inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要